BELGIAN INFUSIONS
ActiveSummary
BELGIAN INFUSIONS has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €629,711 and a net result of €376,510. Equity is growing by about 129% per year across the filed financial years. Its solvency ranks better than 38% of 39,184 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-09
NBB filing
Annual accounts filed
financial year 2025 · micro format · 61 days late
2025
31-12
Financial
Highest result from 2021 to 2025net €376,510 ▲317%
Operating result €522,442, net result €376,510, both a record.
31-12
Financial
Equity above €500,000equity €629,711 ▲210%
A profit in every financial year since 2021 builds equity to €629,711.
09-10
NBB filing
Annual accounts filed
financial year 2024 · micro format · 70 days late
07-05
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- Board meeting, 31-03-2025
- Registered-office move, Chemin de la Longue Bone n°27 7060 Soignies
2024
31-12
Financial
Equity above €200,000equity €202,927 ▲80.1%
A profit in every financial year since 2021 builds equity to €202,927.
26-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 26 days late
2023
31-12
Financial
Equity above €100,000equity €112,679 ▲109%
A profit in every financial year since 2021 builds equity to €112,679.
26-09
NBB filing
Annual accounts filed
financial year 2022 · micro format · 57 days late
2022
11-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 11 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.